CBR3 and breast carcinoma: We further selected five lncRNAs (DSCR8, TP53TG1, CBR3-AS1, LINC01006, HAGLROS) that were not previously reported to be related to the drug sensitivity of breast cancer and performed qRT-PCR to verify their expression levels (Fig. 1d).